ACIU Hisse Senedi Fiyat Grafiği
ACIU Finansal
AC Immune SA
$2.83
-0.7%
$-0.02
Kapanışta: May 22, 16:00:00 GMT-4
$2.83
0%
$0
Sonrası Piyasa: May 22, 20:00:00 GMT-4
Geri
AC Immune SA (ACIU) Finansal
Önemli İstatistikler
Önceki Kapanış
$2.85
Açılış fiyatı
$2.87
Günün Aralığı
$2.81 - $2.91
52 haftalık aralık
$1.6 - $4
İşlem hacmi
78.1K
Ort.Hacim
290.5K
Dividend yield
--
EPS (TTM)
-0.66
Piyasa Değeri
$288.0M
ACIU nedir?
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. The firm focuses on precision medicine for neurodegenerative diseases. The company designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The firm's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. The company has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
